MENU
APR 20 - 22 2021
LIVE NOW!

Genetics Virtual Week 2021

LabRoots is excited to announce our 9th Annual Genetics Virtual Week held on April 20-22, 2021!

Genetics Virtual Week 2021 will offer a multi-day content-rich program combining stellar expertise from world-renowned keynote and featured speakers in the areas of Genetics & Genomics an expanding field of biology and human health, Molecular Diagnostics, exploring best laboratory practices and novel diagnostic applications, and Precision Medicine, spanning innovative technologies and solutions transforming healthcare and changing how patients are treated today.  

Over the three days, invited lectures, thought-provoking discussions, and posters will be presented by academia and industry experts, professionals in medical and clinical genetics, scientific leaders, and research scholars.

This year's Genetics Virtual Week includes the following tracks:

Genetics and Genomics

Advancements in Genomic Technologies

  • Genome Editing
  • Single Cell Genomics
  • Spatial Genomics

Sex, Epigenetics, Aging, and Disease

  • Sex Differences in Disease
  • Epigenetics Clock

New Approaches in the Genetics of Disease

  • Improving GWAS through Functional Filtering
  • Genetic Drivers of Regulatory Networks
  • LRS to increase the solve rate of undiagnosed diseases

Long-read Sequencing

  • Structural Variation
  • Telomere-to-Telomere Genome Assemblies
  • Full-length RNA-Sequencing & Isoform Identification
  • Metagenomics (or complex populations)

 

Molecular Diagnostics

Emerging Technologies and Methodologies in Molecular Diagnostics

  • Trends Towards Higher Complexity (PCR-NGS-single gene sequencing-panels-exome-WGS)
  • High-throughput Technologies
  • Customization and Increased Applicability of Panel Testing (respiratory infection pathogen panels)
  • CRISPR-based Diagnostics

Liquid Biopsies (Cancer Monitoring and Screening)

  • Kits and Panels
  • Companion Diagnostics

Infectious Disease Diagnostics - COVID-19 Testing

  • COVID-19 (Diagnostics: RT-PCR & Antigen)
  • Antibody Testing
  • Public Health and Screening
  • FDA EUA Process & Evolvement
  • Point of Care Testing

 

Precision Medicine

Therapeutics in Precision Medicine

  • Gene Therapy / Nucleic Acid Modification
  • Rare Disease / Orphan
  • Current Status of Companion and Complementary Diagnostics

Precision Medicine in Clinical Practice

  • Pharmacogenomics as a clinical tool
  • Implementation and Adoption of precision medicine in routine clinical care

The Role of Technology in Precision Medicine

  • Artificial Intelligence
  • Software Tools

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.

Enjoy the interactive environment via live-streaming video and chat sessions with peers, and using the Leaderboard and Gamification to move around the entire event, earning points for a chance to win one of LabRoots most popular t-shirts.


Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary and discuss results with interested colleagues through email. Plan now to have your poster included in the 2021 Genetics Virtual Week. Submit your free abstract here.

Continuing Education – LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 50 credits. This event will also provide CEU's for Genetic Counselors and is pending approval by the NSGC.

Use #LRgenetics to follow the conversation!


Speakers

Show Resources
You May Also Like
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
NOV 10, 2021 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Twelveyears ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2021 Clinical Diagnostics and Research Virtual Event will again bring together clinician...
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 09, 2022 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Thirteen years ago Labroots launched a new system of learning for a global scientific audience. Now, the 2022 Clinical Diagnostics and Research Virtual Event will again bring together clinic...
APR 19, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
APR 19, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to announce our 10th Annual Genetics Virtual Week held on April 19-21, 2022! Genetics Virtual Week 2022 will offer a multi-day content-rich program combining stellar expe...
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 07, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7 th Ann...
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 06, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 8th Annu...
MAR 23, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAR 23, 2022 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is pleased to announce the 5th Annual 2021 Cannabis Sciences Virtual Event . LabRoots will host the event on March 23, 2022. The Cannabis Sciences planning committee will be plannin...
Agenda
  • Epigenetic Aging Studies in Mammals
    LIVE NOW!
    LIVE NOW!
    Steve Horvath
    David Geffen School of Medicine, University of California, Los Angeles
  • Keynote Presentation: High-throughput Diagnostics and Sequencing at the Pandemic Response Lab NYC
    LIVE NOW!
    APR 21, 2021 6:00 AM PDT
    LIVE NOW!
    Jon M. Laurent, PhD
    Director, Pandemic Response Labs
  • APR 21, 2021 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Eric Allen, MBA, M. Eng. Bioengineering, Michael Oberholzer, PhD
    Eric Allen, MBA, M. Eng. Bioengineering
    Director, Bioinformatics, Illumina
    Michael Oberholzer, PhD
    Associate Director, Product Management Infectious Disea...
  • Supporting Biomarker Discovery One Cell at a Time - Single cell analysis solutions that drive results and insights
    APR 21, 2021 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Joseph Pearson, PhD
    Global Product Manger
    Sponsored By: QIAGEN
  • APR 21, 2021 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Kyle Hondorp, Marija Navickaitė
    Sponsored By: Thermo Fisher Scientific
    Kyle Hondorp
    Sr. Product Manager, Thermal Cyclers & Plastics, Thermo...
    Marija Navickaitė
    Product Manager, DNA Polymerases, Thermo Fisher
  • Directed evolution - shrinking the haystack with tailor-made synthetic DNA
    APR 21, 2021 12:00 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Dr. Tobias Santl, PhD
    Formulation Manufacturing Manager, Gene Evolution Library Group
    Sponsored By: Thermo Fisher Scientific
Scheduled
  • APR 22, 2021 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Dominic John, Simon Forbes, Shawn Bauer, Lisa Barrow-Laing
    Sponsored By: QIAGEN
    Dominic John
    VP, Marketing & Clinical Product Mgmt, Digital Insights
    Simon Forbes
    Head of COSMIC, Wellcome Sanger Institute, Cambridge, U...
    Shawn Bauer
    Director - Content Engineering, QDI
    Lisa Barrow-Laing
    Associate Staff Field Applications Scientist/Scientific...
  • Keynote Presentation: Moving Precision Medicine from 'Exotic' to 'Normal'
    APR 22, 2021 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Dr. Howard L. McLeod, FASCO, FCCP
    Medical Director, Precision Medicine, Geriatric Oncology Consortium, Professor of Pharmacy and Medicine, University of South Florida Taneja College of Pharmacy
  • APR 22, 2021 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Holly Ellis, MSc, BA, Hannah Stevens, PhD
    Holly Ellis, MSc, BA
    Registered Clinical Scientist, North West Genomic Labor...
    Hannah Stevens, PhD
    Clinical Scientist, Genomics, North West Genomic Labora...
  • Extraction-free sensitive detection of viral RNA using direct RT-PCR chemistry
    APR 22, 2021 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Donald Green
    Senior Field Application Specialist, Genomics and Diagnostics, Cytiva
    Sponsored By: Cytiva
The following webinars will be readily on-demand when the event starts
  • An Introduction to Resources Facilitating Cancer Variant Interpretation
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Beth Pitel, M.S., CG(ASCP)CM
    Assistant Professor and Senior Developer, Genomics Laboratory Mayo Clinic
  • Efficient Implementation of DPYD Testing Using an Institutional Genetics Data Repository
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Daniel L Hertz, PharmD, PhD
    Assistant Professor, University of Michigan College of Pharmacy
  • Laboratory Implementation of Clinical Genomics in Children
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Angshumoy Roy, MD, PhD
    Associate Professor, Department of Pathology & Immunology, Baylor College of Medicine Director of Cancer Genomics, Texas Children's Hospital
  • Phenoconversion: The Achille's Heel of Personalized Medicine
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Behnaz Sarrami, MS, PharmD
    Director of Consulting Missouri Pharmacogenomics Consulting, LLC
  • Using AI and Predictive Algorithms to Help Advanced Cancer Patients Identify the Best Treatment Options
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Kenny Wong, MS CGC
    Chief Product Officer, xCures
  • A Saliva-Based RT-PCR SARS-CoV-2 Detection Assay: Development and Deployment
    Suzie Alarcon, CGMBS, MB(ASCP)ᶜᴹ
    NGS Core Manager La Jolla Institute for Immunology
  • Flex Analysis: A Safe, Integrated and Flexible Approach to Non-Invasive Aneuploidy Analysis
    Matthew C. Forman, PhD
    Head of Bioinformatics & Software, Yourgene Health
  • High Throughput Testing for SARS-CoV-2 and SNP Analysis for Variants of Concern
    Richard Michelmore
    Distinguished Professor and Director, The Genome Center, Genome and Biomedical Sciences Facility, University of California, Davis
  • Hybrid Capture SARS-CoV-2 NGS Assay and COVID-Dx: a robust end to end solution for viral detection and surveillance of genetic variants
    Mara Couto-Rodriguez
    Director of Research and Development, Biotia, Inc
  • Liquid Biopsy-based Detection of Early Stage Gynecological Cancers
    Lesley Northrop, PhD, FACMG
    Chief Scientific Officer Aspira Women's Health
  • Past, Present and Future of Engineered Cell Therapy
    Janani Krishnamurthy, PhD
    Director Drug Development City of Hope
  • Saliva - based testing for SARS-CoV-2 diagnosis
    Orchid Allicock, PhD
    Postdoctoral Research Associate, Yale School of Public Health
  • Saliva pool testing: Fast, affordable, easy and highly accurate testing solution for returning back to school and work
    Prem Premsrirut
    Co-Founder, President and CEO, Mirimus, Inc.
  • The Importance of Hybrid-capture Technology to Recognize and Characterize Viral Threats
    Rebecca Nugent, PhD
    Senior Director of BioPharma Product Strategy Twist Bioscience
  • Advancing AAV: Novel Synthesis and Sequencing Solutions for Gene Therapy Research
    APR 20, 2021 4:30 PM PDT
    Andrea O'Hara, PhD
    Strategic Technical Specialist, GENEWIZ, A Brooks Life Sciences Company
    Sponsored By: GENEWIZ
  • High-throughput clinical and environmental viral extraction and sequencing.
    APR 20, 2021 4:30 PM PDT
    Christopher E. Mason, PhD
    Associate Professor; Director, WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine
    Sponsored By: Tecan
    SEE ABSTRACT | Continuing Education: CEU
  • APR 20, 2021 3:00 PM PDT
    Nathan Henson, MS, Donald Skifter, PhD, MBA
    Sponsored By: QIAGEN
    Nathan Henson, MS
    Product Manager, Biospecimens and Cell Services, Discov...
    Donald Skifter, PhD, MBA
    Sr. Vice President, Genomics, Discovery Life Sciences
  • APR 20, 2021 1:30 PM PDT
    Carina Emery, Alina Steinbach
    Sponsored By: Miltenyi Biotec
    Carina Emery
    Product Manager for Sample Preparation at Miltenyi Biot...
    Alina Steinbach
    Product Manager for Flow Sorting at Miltenyi Biotec
  • High Viability Cell Sorting for Single-Cell 3' RNA-seq & 10x Genomics Applications
    APR 20, 2021 12:00 PM PDT
    Nicole Jagnandan, PhD
    Application Scientist, NanoCellect Biomedical, Inc.
  • Enhancer-Promoter Interactome Drives Neuronal Cell Differentiation and Contextualizes Alzheimer's Associated Polymorphisms
    APR 20, 2021 9:00 AM PDT
    Cory Padilla, PhD
    Head of Scientific Affairs, Dovetail Genomics
    Sponsored By: Dovetail Genomics
  • Keynote Presentation: A structural variation map of 499 Han Chinese individuals using long-read sequencing data
    APR 20, 2021 7:30 AM PDT
    Fritz Sedlazeck, PhD
    Human Genome Sequencing Centre, Baylor College of Medicine
  • APR 20, 2021 6:00 AM PDT
    Brian Dugan, M.S., Fernando Spikli, PhD
    Sponsored By: QIAGEN
    Brian Dugan, M.S.
    Director, Global Product Management, Genomics QIAGEN
    Fernando Spikli, PhD
    Professor, Feevale University, Novo Hamburgo, Brazil
  • Application of Long-read Sequencing in Human Genetics
    Tychele Turner, Ph.D.
    Assistant Professor, Department of Genetics, Washington University in St. Louis
    Sponsored By: PacBio
  • Cell type-specific vulnerability to traumatic brain injury
    Araks Martirosyan, Ph.D.
    Sr. Postdoctoral Researcher Laboratory of Glia Biology, VIB-KU Leuven Center for Brain and Disease Research
  • Deciphering Brain Mosaicism with Long-read Sequencing
    Tracy Bedrosian, Ph.D.
    Principal investigator, Nationwide Children's Hospital; Assistant Professor of Pediatrics, The Ohio State University College of Medicine
  • Defining Cellular Heterogeneity and Cell-Type Specific Pathogenesis in the Retina Using Single Cell RNA-Sequencing
    David Simpson, PhD
    Reader, Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast
  • Developing disease insights with genotype-specific regulatory networks
    John Platig, PhD
    Instructor, Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School
  • Illuminating Biology with Spatially Resolved, Single-cell Transcriptomics
    Jiang He
    Co-founder and Director of Scientific Affairs, Vizgen
  • Integrative Analysis of Single-Cell Combinatorial Long-Read RNA-seq and Single-Cell ATAC-seq in Myogenesis
    Fairlie Reese, PhD Student
    Mortazavi lab, The University of California, Irvine
  • Long-read Genome Sequencing for the Molecular Diagnosis of Neurodevelopmental Disorders
    Gregory Cooper, PhD
    Faculty Investigator, HudsonAlpha Institute for Biotechnology
  • Low error rate long-reads enable the identification of long variant haplotypes in metagenome assemblies
    Derek Bickhart, PhD
    Research Microbiologist/Bioinformatician, US Department of Agriculture's Dairy Forage Research Center
  • Measurement of DNA Methylation and Nuclear Organization with Nanopore Sequencing
    Roham Razaghi, PhD Candidate
    Department of Biomedical Engineering John Hopkins University
  • Practical Considerations and Best Practices for Single Cell and Spatial Transcriptomics
    Neil Winegarden, MSc
    Staff Field Application Scientist, 10X Genomics
  • Sequencing the genome: from genotype to phenotype and a few extras in between
    Rasika Mathias, ScD
    Professor of Medicine, Johns Hopkins, University Director of Genomics, GeneSTAR Research program, General Internal Medicine, Miller-Coulson Family Human Aging Project Scholar...
  • Sex, Gender, the Aging Lung: Epigenetic Findings in COPD
    Dawn DeMeo, M.D., M.P.H.
    Associate Professor of Medicine, Harvard Medical School, Associate Physician, Brigham and Women's Hospital, Department of Medicine
  • Studying Promoter and Isoform Diversity with Long-Read Transcriptome Sequencing
    Jonathan Göke
    Group leader, Genome Institute of Singapore
  • Telomere-to-Telomere Chromosome Assemblies: New Insights Into Genome Biology and Structure
    Karen Miga, PhD
    Assistant Research Scientist; UCSC Genomics Institute, University of California, Santa Cruz
  • The Structure, Function, and Evolution of Human Chromosome 8
    Glennis Logsdon, PhD
    Postdoctoral Research Fellow, Department of Genome Sciences University of Washington
  • Towards a Comprehensive Variation Benchmark for Medically-Relevant Autosomal Genes
    Justin Wagner, PhD
    Computer Scientist, NIST
  • X Chromosome Factors that Contribute to Sex Differences in Disease
    Arthur Arnold, PhD
    Distinguished Research Professor, Department of Integrative Biology & Physiology University of California, Los Angeles
  • Genomics
    • Advancements in Genomic Technologies
    • Defining Cellular Heterogeneity and Cell-Type Specific Pathogenesis in the Retina Using Single Cell RNA-Sequencing
      David Simpson, PhD
      Reader, Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast
    • Illuminating Biology with Spatially Resolved, Single-cell Transcriptomics
      Jiang He
      Co-founder and Director of Scientific Affairs, Vizgen
    • Practical Considerations and Best Practices for Single Cell and Spatial Transcriptomics
      Neil Winegarden, MSc
      Staff Field Application Scientist, 10X Genomics
    • Cell type-specific vulnerability to traumatic brain injury
      Araks Martirosyan, Ph.D.
      Sr. Postdoctoral Researcher Laboratory of Glia Biology, VIB-KU Leuven Center for Brain and Disease Research
    • Long-read Sequencing
    • Telomere-to-Telomere Chromosome Assemblies: New Insights Into Genome Biology and Structure
      Karen Miga, PhD
      Assistant Research Scientist; UCSC Genomics Institute, University of California, Santa Cruz
    • Measurement of DNA Methylation and Nuclear Organization with Nanopore Sequencing
      Roham Razaghi, PhD Candidate
      Department of Biomedical Engineering John Hopkins University
    • Towards a Comprehensive Variation Benchmark for Medically-Relevant Autosomal Genes
      Justin Wagner, PhD
      Computer Scientist, NIST
    • Integrative Analysis of Single-Cell Combinatorial Long-Read RNA-seq and Single-Cell ATAC-seq in Myogenesis
      Fairlie Reese, PhD Student
      Mortazavi lab, The University of California, Irvine
    • Studying Promoter and Isoform Diversity with Long-Read Transcriptome Sequencing
      Jonathan Göke
      Group leader, Genome Institute of Singapore
    • Low error rate long-reads enable the identification of long variant haplotypes in metagenome assemblies
      Derek Bickhart, PhD
      Research Microbiologist/Bioinformatician, US Department of Agriculture's Dairy Forage Research Center
    • Deciphering Brain Mosaicism with Long-read Sequencing
      Tracy Bedrosian, Ph.D.
      Principal investigator, Nationwide Children's Hospital; Assistant Professor of Pediatrics, The Ohio State University College of Medicine
    • Long-read Genome Sequencing for the Molecular Diagnosis of Neurodevelopmental Disorders
      Gregory Cooper, PhD
      Faculty Investigator, HudsonAlpha Institute for Biotechnology
    • Application of Long-read Sequencing in Human Genetics
      Tychele Turner, Ph.D.
      Assistant Professor, Department of Genetics, Washington University in St. Louis
      Sponsored By: PacBio
    • The Structure, Function, and Evolution of Human Chromosome 8
      Glennis Logsdon, PhD
      Postdoctoral Research Fellow, Department of Genome Sciences University of Washington
    • Keynote Presentation: A structural variation map of 499 Han Chinese individuals using long-read sequencing data
      APR 20, 2021 7:30 AM PDT
      Fritz Sedlazeck, PhD
      Human Genome Sequencing Centre, Baylor College of Medicine
    • New Approaches in the Genetics of Disease
    • Sequencing the genome: from genotype to phenotype and a few extras in between
      Rasika Mathias, ScD
      Professor of Medicine, Johns Hopkins, University Director of Genomics, GeneSTAR Research program, General Internal Medicine, Miller-Coulson Family Human Aging Project Scholar...
    • Developing disease insights with genotype-specific regulatory networks
      John Platig, PhD
      Instructor, Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School
    • Sex, Epigenetics, Aging, and Disease
    • Epigenetic Aging Studies in Mammals
      LIVE NOW!
      LIVE NOW!
      Steve Horvath
      David Geffen School of Medicine, University of California, Los Angeles
    • X Chromosome Factors that Contribute to Sex Differences in Disease
      Arthur Arnold, PhD
      Distinguished Research Professor, Department of Integrative Biology & Physiology University of California, Los Angeles
    • Sex, Gender, the Aging Lung: Epigenetic Findings in COPD
      Dawn DeMeo, M.D., M.P.H.
      Associate Professor of Medicine, Harvard Medical School, Associate Physician, Brigham and Women's Hospital, Department of Medicine
  • APR 20, 2021 6:00 AM PDT
    Brian Dugan, M.S., Fernando Spikli, PhD
    Sponsored By: QIAGEN
    Brian Dugan, M.S.
    Director, Global Product Management, Genomics QIAGEN
    Fernando Spikli, PhD
    Professor, Feevale University, Novo Hamburgo, Brazil
  • High Viability Cell Sorting for Single-Cell 3' RNA-seq & 10x Genomics Applications
    APR 20, 2021 12:00 PM PDT
    Nicole Jagnandan, PhD
    Application Scientist, NanoCellect Biomedical, Inc.
  • APR 20, 2021 1:30 PM PDT
    Carina Emery, Alina Steinbach
    Sponsored By: Miltenyi Biotec
    Carina Emery
    Product Manager for Sample Preparation at Miltenyi Biot...
    Alina Steinbach
    Product Manager for Flow Sorting at Miltenyi Biotec
  • APR 20, 2021 3:00 PM PDT
    Nathan Henson, MS, Donald Skifter, PhD, MBA
    Sponsored By: QIAGEN
    Nathan Henson, MS
    Product Manager, Biospecimens and Cell Services, Discov...
    Donald Skifter, PhD, MBA
    Sr. Vice President, Genomics, Discovery Life Sciences
  • High-throughput clinical and environmental viral extraction and sequencing.
    APR 20, 2021 4:30 PM PDT
    Christopher E. Mason, PhD
    Associate Professor; Director, WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine
    Sponsored By: Tecan
    SEE ABSTRACT | Continuing Education: CEU
  • Molecular Diagnostics
    • Emerging Technologies and Methodologies in Molecular Diagnostics
    • Flex Analysis: A Safe, Integrated and Flexible Approach to Non-Invasive Aneuploidy Analysis
      Matthew C. Forman, PhD
      Head of Bioinformatics & Software, Yourgene Health
    • Past, Present and Future of Engineered Cell Therapy
      Janani Krishnamurthy, PhD
      Director Drug Development City of Hope
    • The Importance of Hybrid-capture Technology to Recognize and Characterize Viral Threats
      Rebecca Nugent, PhD
      Senior Director of BioPharma Product Strategy Twist Bioscience
    • Infectious Disease Diagnostics - COVID 19 - Testing
    • High Throughput Testing for SARS-CoV-2 and SNP Analysis for Variants of Concern
      Richard Michelmore
      Distinguished Professor and Director, The Genome Center, Genome and Biomedical Sciences Facility, University of California, Davis
    • APR 21, 2021 7:30 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Eric Allen, MBA, M. Eng. Bioengineering, Michael Oberholzer, PhD
      Eric Allen, MBA, M. Eng. Bioengineering
      Director, Bioinformatics, Illumina
      Michael Oberholzer, PhD
      Associate Director, Product Management Infectious Disea...
    • Infectious Disease Diagnostics - COVID 19 Testing
    • A Saliva-Based RT-PCR SARS-CoV-2 Detection Assay: Development and Deployment
      Suzie Alarcon, CGMBS, MB(ASCP)ᶜᴹ
      NGS Core Manager La Jolla Institute for Immunology
    • Saliva - based testing for SARS-CoV-2 diagnosis
      Orchid Allicock, PhD
      Postdoctoral Research Associate, Yale School of Public Health
    • Keynote Presentation: High-throughput Diagnostics and Sequencing at the Pandemic Response Lab NYC
      LIVE NOW!
      APR 21, 2021 6:00 AM PDT
      LIVE NOW!
      Jon M. Laurent, PhD
      Director, Pandemic Response Labs
    • Infectious Disease Diagnostics - COVID 19- Testing
    • Hybrid Capture SARS-CoV-2 NGS Assay and COVID-Dx: a robust end to end solution for viral detection and surveillance of genetic variants
      Mara Couto-Rodriguez
      Director of Research and Development, Biotia, Inc
    • Saliva pool testing: Fast, affordable, easy and highly accurate testing solution for returning back to school and work
      Prem Premsrirut
      Co-Founder, President and CEO, Mirimus, Inc.
    • Liquid Biopsies (Cancer Monitoring and Screening)
    • Liquid Biopsy-based Detection of Early Stage Gynecological Cancers
      Lesley Northrop, PhD, FACMG
      Chief Scientific Officer Aspira Women's Health
  • Supporting Biomarker Discovery One Cell at a Time - Single cell analysis solutions that drive results and insights
    APR 21, 2021 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Joseph Pearson, PhD
    Global Product Manger
    Sponsored By: QIAGEN
  • APR 21, 2021 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Kyle Hondorp, Marija Navickaitė
    Sponsored By: Thermo Fisher Scientific
    Kyle Hondorp
    Sr. Product Manager, Thermal Cyclers & Plastics, Thermo...
    Marija Navickaitė
    Product Manager, DNA Polymerases, Thermo Fisher
  • Directed evolution - shrinking the haystack with tailor-made synthetic DNA
    APR 21, 2021 12:00 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Dr. Tobias Santl, PhD
    Formulation Manufacturing Manager, Gene Evolution Library Group
    Sponsored By: Thermo Fisher Scientific
  • Precision Medicine
    • Precision Medicine in Clinic
    • Laboratory Implementation of Clinical Genomics in Children
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Angshumoy Roy, MD, PhD
      Associate Professor, Department of Pathology & Immunology, Baylor College of Medicine Director of Cancer Genomics, Texas Children's Hospital
    • Efficient Implementation of DPYD Testing Using an Institutional Genetics Data Repository
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Daniel L Hertz, PharmD, PhD
      Assistant Professor, University of Michigan College of Pharmacy
    • Phenoconversion: The Achille's Heel of Personalized Medicine
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Behnaz Sarrami, MS, PharmD
      Director of Consulting Missouri Pharmacogenomics Consulting, LLC
    • Keynote Presentation: Moving Precision Medicine from 'Exotic' to 'Normal'
      APR 22, 2021 7:30 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Dr. Howard L. McLeod, FASCO, FCCP
      Medical Director, Precision Medicine, Geriatric Oncology Consortium, Professor of Pharmacy and Medicine, University of South Florida Taneja College of Pharmacy
    • APR 22, 2021 9:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Holly Ellis, MSc, BA, Hannah Stevens, PhD
      Holly Ellis, MSc, BA
      Registered Clinical Scientist, North West Genomic Labor...
      Hannah Stevens, PhD
      Clinical Scientist, Genomics, North West Genomic Labora...
    • The Role of Technology in Precision Medicine
    • Using AI and Predictive Algorithms to Help Advanced Cancer Patients Identify the Best Treatment Options
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Kenny Wong, MS CGC
      Chief Product Officer, xCures
    • An Introduction to Resources Facilitating Cancer Variant Interpretation
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Beth Pitel, M.S., CG(ASCP)CM
      Assistant Professor and Senior Developer, Genomics Laboratory Mayo Clinic
Speakers

  • Suzie Alarcon, CGMBS, MB(ASCP)ᶜᴹ
    NGS Core Manager La Jolla Institute for Immunology
    Biography

      Suzie Alarcon CGMBS, MB(ASCP)CM is the manager of the Next Generation Sequencing Core at the La Jolla Institute for Immunology (LJI) and Team Leader of Team LJI - winner of the XPRIZE Rapid COVID Testing competition. Suzie has 18 years of experience working in molecular biology in taste, nutrition metabolomics, prenatal clinical diagnostics, epigenetics, and immunology. Her current work focuses on driving research endeavors of collaborators across the US and applies her varied experience to advise on technical development and optimization of NGS upstream workflows. She received her BS in Biology from Ursinus College, PA, US and her clinical training at Sequenom, CA, US.

    • Eric Allen, MBA, M. Eng. Bioengineering
      Director, Bioinformatics, Illumina
      Biography

        Mr. Allen has over 30 years of experience in the fields of bioinformatics and software development.  He is currently Director, Bioinformatics at Illumina, Inc and is the software lead for several cloud based analysis products supporting oncology, genetic disease, and microbiology related studies using whole genome sequencing, targeted sequencing, RNASeq, bisulfite sequencing, and/or metagenomics types of library preps.  Most recently, he has led the teams for several COVID related data analysis products.  Prior to Illumina, Mr. Allen also worked in a variety of software and data analysis roles for companies such as IBM, AT&T, Oracle, and Neurocrine Biosciences.  Mr. Allen received his degrees from the University of Michigan in Ann Arbor, MI, the University of Texas in Austin, TX, and the University of San Diego in La Jolla, CA.

      • Orchid Allicock, PhD
        Postdoctoral Research Associate, Yale School of Public Health
        Biography

          Orchid Allicock is a postdoctoral research associate at Yale School of Public Health with Drs. Nathan Grubaugh and Daniel Weinberger. Previously she received postdoctoral training at the Mailman School of Public Health, Columbia University, where she gained an interest in translational science and diagnostic development. Currently she works on development and optimization of saliva-based diagnostics with SalivaDirect.

        • Arthur P. Arnold, PhD
          Distinguished Research Professor, Department of Integrative Biology & Physiology University of California, Los Angeles
          Biography

            Arthur P. Arnold (AB, Grinnell College; PhD, The Rockefeller University) studies mechanisms causing sex differences in physiology and disease.  His research has included the discovery of large structural sexual dimorphisms in the CNS, development of several animal models for studying sex differences, and studies of mechanisms by which sex-biasing factors operate, including sex chromosome effects. Dr. Arnold is Distinguished Research Professor in the Department of Integrative Biology & Physiology at UCLA, and a fellow of the AAAS and the John Simon Guggenheim Memorial Foundation. Previous positions include departmental Chair, Associate Director of the UCLA Brain Research Institute, Chair of the UCLA interdepartmental PhD and undergraduate programs for neuroscience, founding President of the Society of Behavioral Neuroendocrinology, and founding Editor-in-Chief of Biology of Sex Differences.

          • Lisa Barrow-Laing
            Associate Staff Field Applications Scientist/Scientific Liaison
            Biography

              Dr. Lisa Barrow-Laing has over 15 year of experience in the areas of oncology, rare disease and virology.  Currently, Dr. Barrow-Laing serves as a Scientific Liaison frequently delivering workshops, trainings and product demonstrations on QIAGEN's bioinformatics offerings to oncologists, molecular pathologists, genetic counselors and other lab personnel. She assists customers with identifying the best secondary and tertiary analysis solutions to support various tests, including hereditary cancer panel and clinical exome testing. Prior to joining QIAGEN, Dr. Barrow-Laing was a Biomedical Informatics Scientist at Illumina and led clinical guideline curation projects for the Genomics England 100,000 Genome Project and clinical trial curation efforts for the ASCO TAPUR Study to identify biomarkers associated with drug sensitivity and drug resistance. She also interpreted variants and generated patient reports for pediatric patients with rare disease and cancer patients at the Illumina Clinical laboratory and N-of-One, respectively . She pursued her post-doctoral training at Brigham and Women's Hospital/Harvard Medical School and earned her Ph.D. at The Indiana University School of Medicine. 

            • Shawn Bauer
              Director - Content Engineering, QDI
              Biography

                Dr. Shawn Bauer is the Director of Content Engineering at QIAGEN Digital Insights (QDI) and is responsible for scientific and bioinformatic content modeling and processing within QDI which support QIAGEN Digital Insight – Interpret (QCI-I), OmicSoftSuite, and Ingenuity Pathway Analysis (IPA). Prior to joining QIAGEN Dr. Bauer worked in drug discovery as Director of Medicinal Chemistry at Portola Pharmaceuticals where he worked on a variety of small molecule drug targets, the most recent of which led to the discovery of cerdulatinib which is currently in clinical development for leukemia and lymphoma. Dr. Bauer earned his Ph.D. in Organic Chemistry from University of California, Los Angeles.

              • Tracy Bedrosian, Ph.D.
                Principal investigator, Nationwide Children's Hospital; Assistant Professor of Pediatrics, The Ohio State University College of Medicine
                Biography

                  Tracy Bedrosian leads a laboratory in the Institute for Genomic Medicine at Nationwide Children's Hospital. Her group uses single-cell sequencing approaches to understand how brain somatic mutations contribute to neurodevelopmental disorders, including developmental brain malformations, epilepsy, and autism. She also serves as an Assistant Professor of Pediatrics at The Ohio State University.

                • Derek Bickhart, PhD
                  Research Microbiologist/Bioinformatician, US Department of Agriculture's Dairy Forage Research Center
                  Biography

                    Dr. Bickhart is a Research Microbiologist/Bioinformatician at the US Department of Agriculture's Dairy Forage Research Center, where his work focuses on genome assembly of livestock species and their associated microbiomes. He has 10 years of experience in the field of Bioinformatics and Genome Informatics, and applies new technologies and algorithms to solve problems in agricultural production systems. Dr. Bickhart has been a contributor or team leader for many of the recently released reference genomes for agricultural species. The goal of this research is to improve the sustainability of agricultural systems by enabling predictive modeling of animal production with the inclusion of animal and microbial genomic information.

                  • Matthew C. Forman, PhD
                    Head of Bioinformatics & Software, Yourgene Health
                    Biography

                      Dr. Matthew Forman is Head of Bioinformatics & Software at Yourgene Health,  an international molecular diagnostics group which develops, manufactures, and commercialises simple and accurate molecular diagnostic solutions, for reproductive health, precision medicine and infectious diseases. The Group's flagship products include non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, and a recent extension into the oncology space with DPYD genotyping.

                      Dr. Forman joined Yourgene Health in 2013 and initially led the development of a complete turnkey solution to NGS data analysis and clinical reporting for NIPT, developed according to stringent IVD software process standards. He and his team have substantial experience of the end-to-end development of bioinformatic, biomedical and technical software systems. This begins with the design of novel bioinformatic data processing algorithms applying statistical modelling and machine learning techniques, and then manages the medical device software development lifecycle through to integration and formal testing of software modules, and finally to validation and regulatory approval of complete IVD software products.

                      Dr. Forman has held senior positions in research and commercial development of algorithms and software systems for medical visualisation, ultrasound and electrical impedance tomography at De Montfort University, Create3D and WZVI Ltd, developing a thorough appreciation of the statistical nature of real world genetic and biomedical data together with practical knowledge of software development methods, hardware, operating system and laboratory systems integration. He holds a B.Eng (hons) in Electronic Engineering and a Ph.D in the field of three-dimensional image processing and compression.

                    • Gregory Cooper, PhD
                      Faculty Investigator, HudsonAlpha Institute for Biotechnology
                      Biography

                        Greg Cooper, PhD, is a faculty investigator at the HudsonAlpha Institute for Biotechnology. Throughout his career, Cooper has focused on understanding the structures, functions and evolutionary histories of human genomes and finding ways to translate that understanding into useful predictions about human health and disease. Cooper earned a PhD in genetics from Stanford University in 2006. He completed postdoctoral research at the University of Washington in 2009 before joining HudsonAlpha in 2010.

                      • Mara Couto-Rodriguez
                        Director of Research and Development, Biotia, Inc
                        Biography

                          Mara has over 15 years of experience working in the fields of microbiome, fungal genetics and bacterial diversity. As a Senior Staff Associate at Columbia University, she conducted research on diverse human microbiome projects employing next-generation sequencing techniques. This research provided greater insight into the role of the microbiome in health and disease; including stillbirth, HIV, bacterial vaginosis, colorectal cancer and maternal antibiotic exposure during pregnancy. Currently, Mara is the Director of Research & Development at Biotia, a NYC-based startup focusing on clinical diagnostics and surveillance by leveraging genomics and AI for precision infectious disease insights. Mara holds a master's degree in Fungal Genetics from the University of Georgia along with a master's degree in Microbiology from the University of Puerto Rico-Mayagüez, where she also earned her BS in Biology.

                        • Dawn DeMeo, M.D., M.P.H.
                          Associate Professor of Medicine, Harvard Medical School, Associate Physician, Brigham and Women's Hospital, Department of Medicine
                          Biography

                            Dawn L. DeMeo, MD, MPH is a Respiratory Epidemiologist at the Channing Division of Network Medicine and a trained Pulmonary/Critical Care Physician; she is an Associate Physician in the Department of Medicine at Brigham and Women's Hospital and an Associate Professor of Medicine at Harvard Medical School. Her primary research interest is genetics and epigenetics as they relate to lung health, lung disease and intersections with sex, gender and aging. To pursue her interest in understanding COPD susceptibility, including the role of genetics and epigenetics in early-onset COPD and sex differences, she has been the recipient of grants from the National Institutes of Health, the American Lung Association and the Alpha 1 Foundation. Dr. DeMeo's vision includes streamlining effective multidisciplinary care for lung diseases through careful scientific investigations, with an eventual goal of designing and implementing genomic insights into diagnostics, therapeutics, and preventative strategies for COPD, informed by “Big Data” and Network Medicine approaches inclusive of age, sex and gender aware approaches.

                          • Brian Dugan, M.S.
                            Director, Global Product Management, Genomics QIAGEN
                            Biography

                              Brian Dugan received his M.S. from Georgetown University in molecular biology. Previously he  worked in marketing and business development positions for NGS testing, as well as research at Eunice Shriver NICHD. Brian is Associate Director for QIAGEN's UNGS Microbiomics portfolio.

                            • Christopher E. Mason, PhD
                              Associate Professor; Director, WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine
                              Biography

                                Dr. Christopher Mason is an Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction, as well as an affiliate of Memorial Sloan Kettering Cancer Center (MSKCC), Rockefeller University, Harvard Medical School, and Yale Law School. The Mason laboratory develops and deploys new biochemical and computational methods in functional genomics to elucidate the genetic basis of human disease and physiology. We create and deploy novel techniques in next-generation sequencing and algorithms for: tumor evolution, genome evolution, DNA and RNA modifications, and genome/epigenome engineering. We also work closely with NIST/FDA to build international standards for these methods (SEQC2, IMMSA, and Epigenomics QC groups), to ensure clinical-quality genome measurements and editing. We also work with NASA to build integrated molecular portraits of genomes, epigenomes, transcriptomes, and metagenomes for astronauts, which help establish the molecular foundations and genetic defenses for enabling long-term human spaceflight. He has won the NIH's Transformative R01 Award, the NASA Group Achievement Award, the Pershing Square Sohn Cancer Research Alliance Young Investigator award, the Hirschl-Weill-Caulier Career Scientist Award, the Vallee Scholar Award, the CDC Honor Award for Standardization of Clinical Testing, and the WorldQuant Foundation Scholar Award. He was named as one of the "Brilliant Ten" Scientists by Popular Science, featured as a TEDMED speaker, and called "The Genius of Genetics" by 92Y. He has >200 peer-reviewed papers and scholarly works that have been featured on the covers of Nature, Science, Cell, Nature Biotechnology, Nature Microbiology, and Neuron, as well as legal briefs cited by the U.S. District Court and U.S. Supreme Court. Coverage of his work has also appeared on the covers of the Wall Street Journal, New York Times, TIME, The LA Times, and across many media (ABC, NBC, CBS, Fox, CNN, PBS, NASA, NatGeo). He is an inventor on four patents, co-founded five biotechnology start-up companies, and serves as an advisor to many others.

                              • Holly Ellis, MSc, BA
                                Registered Clinical Scientist, North West Genomic Laboratory Hub (Liverpool) Manchester Centre for Genomic Medicine Liverpool Women's Hospital
                                Biography

                                  Holly Ellis completed her undergraduate degree in Biological Sciences at Oxford University and then went on to complete an MSc in Medical Genetics at Chester University. She gained another MSc in Clinical Sciences (Genomics) as part of the NHS Scientist Training Programme and she now work as a HCPC Registered Clinical Scientist in Genomics at North West Genomic Laboratory Hub (Liverpool). Holly has developed her own YouTube channel and social media platforms as "The Scouse Scientist" to inspire the next generation of scientists and raise awareness of the importance of genomics in the NHS.

                                • Carina Emery
                                  Product Manager for Sample Preparation at Miltenyi Biotec
                                  Biography

                                    Carina Emery earned a BS in biochemistry from the University of Florida and an MS in life sciences from Northwestern University. At Northwestern she used a variety of mouse models to study the molecular basis of genetic disorders affecting the nervous system. The San Diego resident then spent time in the Core Genomics facility at the University of Illinois at Chicago, where she developed a passion for utilizing the latest genomic technologies to advance research. Carina moved onto becoming a Field Applications Scientist for Bio-Rad Laboratories, supporting their digital PCR and single-cell sequencing systems. Providing technical assistance to a wide variety of researchers afforded her the firsthand knowledge that no matter how advanced your molecular analysis technology, it doesn't necessarily compensate for poor quality starting material. These days, as Product Manager for Sample Preparation at Miltenyi Biotec, the dedicated biotech professional focuses on finding solutions to ensure researchers begin their experiments armed with the best possible materials.

                                  • Simon Forbes
                                    Head of COSMIC, Wellcome Sanger Institute, Cambridge, UK
                                    Biography

                                      I lead the development of the COSMIC database (https://cancer.sanger.ac.uk), which describes millions of somatic mutations across every form of human cancer. Combining genetic research experience in Immunology at Cambridge University and Oncology at Imperial College London with Computer Science at Manchester University, I have an in-depth understanding of how genetic variants impact human phenotypes, and the knowledge of how to deploy bioinformatic solutions in precision medicine. We started COSMIC over 20 years ago as the explosion in recorded cancer genes was only just beginning; we focused on modelling both genotypic and phenotypic annotations at high resolution and this has proved essential to our broad usefulness. Ever since, our expert postdoctoral curators have been gathering ever-greater quantities of data across every mechanism of mutation that drives cancer. By ensuring resolution and precision of this information, described using the best most accessible standards, COSMIC is now a key global resource in precision oncology.

                                    • Jonathan Göke
                                      Group leader, Genome Institute of Singapore
                                      Biography

                                        Dr. Jonathan Göke is a group leader at the Genome Institute of Singapore. Jonathan's research focuses on computational transcriptomics with a particular interest in third generation RNA-Sequencing and computational methods development. He received his PhD in Computational Biology from the Max Planck Institute for Molecular Genetics in Berlin (Germany). His team has contributed to the Pan-Cancer-Analysis-of-Whole-Genomes consortium (PCAWG) and won the DREAM challenge to predict high risk Multiple Myeloma patients. You can find out more about his research, team, and methods under http://www.jglab.org and https://github.com/GoekeLab

                                      • Donald Green
                                        Senior Field Application Specialist, Genomics and Diagnostics, Cytiva
                                        Biography

                                          Donald has worked in a variety of disciplines related to the field of molecular research. He began his research career in Biomedical Engineering at Mississippi State University and later in Neuroscience studying Autism Spectrum Disorders at the University of Mississippi Medical Center. Over the past eleven years, he has worked in the research industry for well-established life sciences organizations in several roles, including, Field Engineering Specialist, Field Application Specialist, and Clinical Application Specialist. Along his varied path he has gained experience in clinical diagnostics, lab developed tests, and helping develop start-ups focused on Next Generation Sequencing (NGS) using targeted sequencing for Oncology. He continues to use his knowledge to help get new and older labs up and running with new assays or projects. Whether it is contributing to a new kit or instrument development, he enjoys working through the process.  Donald values assisting biotech companies and labs find solutions for problems as they grow and adapt to the continuously changing tech landscape. For him watching them get to the next level is one of the most rewarding aspects of his job. If you were to peek at his personality profile, you would see his core skill set is what you call an integrator, meaning he specializes in bringing multifaceted teams together to drive goals to completion. What Donald genuinely wants above all else is to help labs kickstart and achieve their goals allowing them to continue to use science to make it a safer and healthier world.

                                        • Jiang He
                                          Co-founder and Director of Scientific Affairs, Vizgen
                                          Biography

                                            Co-founder of Vizgen, Jiang He completed his postdoc at MIT in Dr. Sangeeta Bhatia's lab, and Ph.D. at Harvard University in Dr. Xiaowei Zhuang's lab. He has extensive experience in developing single molecule imaging techniques and applying them to study different biological questions, including neuroscience, cancer biology, infectious disease. Jiang has been recognized with numerous awards including Forbes 30 under 30 in Healthcare, Spotlight Scholar at AIF, and STAT Wunderkind awardee. 

                                          • Nathan Henson, MS
                                            Product Manager, Biospecimens and Cell Services, Discovery Life Sciences
                                            Biography

                                              Nathan studies biology and graduated from The University of Alabama in Huntsville in 2014. He quickly entered the workforce handling the logistics of biological samples at Lifesouth Community Blood Centers (2014) and Conversant Bio (2017). Nathan then began serving as a feasibility associate and was responsible for evaluating all prospective customer projects. He currently serves as the Product Manager for Biospecimens and CellServices at Discovery Life Sciences. 

                                            • Kyle Hondorp
                                              Sr. Product Manager, Thermal Cyclers & Plastics, Thermo Fisher
                                              Biography

                                                Kyle Hondorp earned her Bachelor of Science in Genetics at the University of California, Davis. She spent 18 years working for Active Motif, a life sciences company focused on providing solutions for epigenetic research, where she held roles in R&D, manufacturing, technical support and product management. In 2008, she earned her Master of Business Administration at California State University, San Marcos. Kyle joined Thermo Fisher Scientific in 2018 and is currently a Sr. Manager, Product Management for the Applied Biosystems™ PCR plastics and thermal cycler portfolios. Kyle is dedicated to providing PCR workflow solutions.

                                              • Steve Horvath
                                                David Geffen School of Medicine, University of California, Los Angeles
                                                Biography

                                                  Dr Horvath's research lies at the intersection of aging research, epidemiology, chronic diseases, epigenetics, genetics, and systems biology. He works on all aspects of biomarker development with a particular focus on genomic biomarkers of aging. He developed a highly accurate multi-tissue biomarker of aging known as the epigenetic clock. Dr Horvath developed systems biologic approaches such as weighted gene co-expression network analysis which lend themselves for integrating gene genomic data sets. These methods have been used for a broad spectrum of age related diseases including neurodegenerative diseases, cancer, cardiovascular disease. Dr. Horvath received a Ph.D. in Mathematics from the University of North Carolina, Chapel Hill in 1995 and a Doctorate of Science in Biostatistics from the Harvard School of Public Health in 2000.

                                                • Nicole Jagnandan, PhD
                                                  Application Scientist, NanoCellect Biomedical, Inc.
                                                  Biography

                                                    Nicole received her Ph.D. in Microbiology from the University of California, Riverside where gained extensive research experience in viral immunology.  Nicole is also a ASCP board certified Specialist in Cytometry and leads the development of our genomic cell sorting applications.

                                                  • Dominic John
                                                    VP, Marketing & Clinical Product Mgmt, Digital Insights
                                                    Biography

                                                      Dr. Dominic John is the VP of Clinical Product Management and Marketing at QIAGEN. Dominic is responsible for overseeing the QIAGEN Digital Insights marketing programs and Clinical Products that have been used in genomic profiling of over 2M patient cases worldwide for oncology and hereditary disease diagnosis.  Dominic has spent over 20 years researching, developing and delivering leading cheminformatics and bioinformatics software to push the boundaries of science from bench to bedside applications. Driven by scientific curiosity, Dominic brings a range of experience from lab informatics, automation, simulation, data science and clinical decision support software. Dominic possesses a master in Toxicology, Ph.D. in Biochemistry and a carried out a Post Doctorate in Genomics.

                                                    • Daniel L Hertz, PharmD, PhD
                                                      Assistant Professor, University of Michigan College of Pharmacy
                                                      Biography

                                                        Dr. Hertz is an assistant professor in the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy. Dr. Hertz received his PharmD from Rutgers University and PhD from UNC for his dissertation research on pharmacogenetic predictors of taxane-induced neuropathy. Dr. Hertz's current research is interested in developing tools for individualizing treatment in patients with cancer and translating them into clinical practice. He has a particular interest in optimal use of paclitaxel for women with breast cancer, including identification of an ideal exposure target to maximize efficacy while avoiding unnecessary toxicity. Dr. Hertz has several other ongoing projects to discover and translate genetic variants that affect cancer treatment outcomes, in collaborations with medical oncologists at the University of Michigan Rogel Cancer Center and within SWOG.

                                                      • Dr. Howard L. McLeod, FASCO, FCCP
                                                        Medical Director, Precision Medicine, Geriatric Oncology Consortium, Professor of Pharmacy and Medicine, University of South Florida Taneja College of Pharmacy
                                                        Biography

                                                          Dr Howard McLeod is an internationally recognized expert in precision medicine, having made novel contributions at the discovery, translation, implementation, and policy levels.  He is the Medical Director for Precision Medicine at the Geriatric Oncology Consortium and a Professor at the University of South Florida Taneja College of Pharmacy.  Dr McLeod chaired the NHGRI eMERGE network external scientific panel for the past decade and was a recent member of both the FDA committee on Clinical Pharmacology and the NIH Human Genome Advisory Council.  Dr McLeod has been recognized as a Fellow of both the American Society of Clinical Oncology and the American College of Clinical Pharmacy and was recently ranked #1 USA/#2 World for Pharmacogenomics.  He has also been an active Board Member and/or Founder for over a dozen privately held and publicly traded companies.  Howard has published over 575 peer reviewed papers on pharmacogenomics, applied therapeutics, or clinical pharmacology and continues to work to advance innovative healthcare.